Search

everythinglearnresearchcommunity

for

Search:↓

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Alopecia areata patients have more Propionibacterium acnes and less Staphylococcus epidermidis on their scalps.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

CBD may improve skin and hair health, but its effective use and safety need more research.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Dermoscopy is useful for many health professionals, not just dermatologists, in improving skin condition diagnoses and reducing unnecessary biopsies.

People with certain types of alopecia have a slightly higher risk of cancer, especially thyroid, bladder, and prostate cancers.

Oxidative stress is important in causing alopecia areata.

Most pregnant women experience common skin changes like linea nigra and stretch marks.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

SLE should be considered in unexplained fevers, even in males.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

People with cutaneous Lichen Planus are more likely to have Metabolic Syndrome and related conditions like high cholesterol, diabetes, and high blood pressure.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

The nail matrix has a reduced immune response, protecting it from autoimmunity.

The skin acts like an endocrine organ, producing hormones that affect various body functions and skin health, and understanding this can lead to new treatments.

Nail disorders not caused by infection are common and can look similar, with psoriasis being the most frequent and having specific nail symptoms.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Hair transplantation is a treatment for hair loss mainly caused by genetics, with various techniques and potential complications, and results visible after 8-12 months.